Stayble Therapeutics AB (publ) (STO:STABL)
Sweden · Delayed Price · Currency is SEK 0.1684
-0.0022 (-1.29%)
Mar 18, 2026, 5:29 PM CET
Stayble Therapeutics AB Market Cap
Stayble Therapeutics AB has a market cap or net worth of 10.84 million as of March 18, 2026. Its market cap has decreased by -40.47% in one year.
Market Cap
10.84M
Enterprise Value
9.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
Market Cap Chart
Since March 9, 2020, Stayble Therapeutics AB's market cap has decreased from 66.74M to 10.84M, a decrease of -83.76%. That is a compound annual growth rate of -26.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 10.84M | -25.16% |
| Dec 30, 2025 | 14.48M | -35.06% |
| Dec 30, 2024 | 22.30M | 131.99% |
| Dec 29, 2023 | 9.61M | -82.65% |
| Dec 30, 2022 | 55.39M | -36.71% |
| Dec 30, 2021 | 87.51M | 28.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pila Pharma AB | 53.54M |
| Nanologica AB | 36.67M |
| Modus Therapeutics Holding AB | 34.18M |
| Guard Therapeutics International AB | 31.36M |
| 2cureX AB | 31.00M |
| Aptahem AB | 19.13M |
| ExpreS2ion Biotech Holding AB | 18.25M |
| Fluicell AB | 15.11M |